Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionRNA-DNA hybrid ribonuclease activity

ERVK-6 ERVK-7 ERVK-10 ERVK-11 ERVK-8 EXO1 RNASEH1

3.23e-12112037GO:0004523
GeneOntologyMolecularFunctionRNA endonuclease activity, producing 5'-phosphomonoesters

ERVK-6 ERVK-7 ERVK-10 ERVK-11 ERVK-8 EXO1 RNASEH1

8.05e-08372037GO:0016891
GeneOntologyMolecularFunctionaspartic-type endopeptidase activity

ERVK-6 ERVK-7 ERVK-10 ERVK-18 ERVK-19 ERVK-25 ERVK-8

8.05e-08372037GO:0004190
GeneOntologyMolecularFunctionaspartic-type peptidase activity

ERVK-6 ERVK-7 ERVK-10 ERVK-18 ERVK-19 ERVK-25 ERVK-8

9.78e-08382037GO:0070001
GeneOntologyMolecularFunctionRNA-directed DNA polymerase activity

ERVK-6 ERVK-7 ERVK-10 ERVK-11 ERVK-8

1.92e-07142035GO:0003964
GeneOntologyMolecularFunctionendonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters

ERVK-6 ERVK-7 ERVK-10 ERVK-11 ERVK-8 EXO1 RNASEH1

3.87e-07462037GO:0016893
GeneOntologyMolecularFunctionRNA stem-loop binding

ERVK-6 ERVK-7 ERVK-10 ERVK-11 ERVK-8

1.84e-06212035GO:0035613
GeneOntologyMolecularFunctionRNA endonuclease activity

ERVK-6 ERVK-7 ERVK-10 ERVK-11 ERVK-8 EXO1 RNASEH1

1.58e-05792037GO:0004521
GeneOntologyMolecularFunctionDNA polymerase activity

ERVK-6 ERVK-7 ERVK-10 ERVK-11 ERVK-8

3.95e-05382035GO:0034061
GeneOntologyMolecularFunctionRNA nuclease activity

ERVK-6 ERVK-7 ERVK-10 PAN2 ERVK-11 ERVK-8 EXO1 RNASEH1

7.70e-051362038GO:0004540
GeneOntologyMolecularFunctiontransferase activity, transferring phosphorus-containing groups

TRPM6 ERVK-6 SMG1 OBSCN AASDHPPT ERVK-7 ERVK-10 BCR PIK3CG PI4KA BUB1B POLR1B ERVK-11 RAF1 BRSK2 PI4KAP2 CASK SCYL2 ART3 PRKACA ERVK-8 PRKCB ROS1

8.72e-0593820323GO:0016772
GeneOntologyMolecularFunctioncholesterol dehydrogenase activity

HSD3B1 HSD3B2

1.03e-0422032GO:0102294
GeneOntologyMolecularFunctionzinc ion binding

ERVK-6 MBTD1 MYCBP2 ERVK-7 ERVK-10 TRIM14 USP51 SF3A3 ERVK-19 POLR1B MMP2 DMD ERVK-11 ALPG PITRM1 KDM5A CPB2 ACE2 ZFAND1 SYTL4 ERVK-8 PRKCB

1.13e-0489120322GO:0008270
GeneOntologyMolecularFunctionpeptidase activity

ERVK-6 ERVK-7 ERVK-10 SENP1 USP51 ERVK-18 PAN2 C1S ERVK-19 ERVK-25 MMP2 NAALAD2 PITRM1 CPB2 ACE2 ERVK-8 ATG4D CTSV

1.31e-0465420318GO:0008233
GeneOntologyMolecularFunctionendopeptidase activity

ERVK-6 ERVK-7 ERVK-10 SENP1 ERVK-18 C1S ERVK-19 ERVK-25 MMP2 PITRM1 ACE2 ERVK-8 ATG4D CTSV

1.36e-0443020314GO:0004175
GeneOntologyMolecularFunctionGTPase binding

MYCBP2 NCF2 RABGAP1 ARHGAP44 RAF1 SYTL4 PRKACA DEPDC5 RIMS1 BECN1 XPOT PLCE1

3.32e-0436020312GO:0051020
GeneOntologyMolecularFunctiontransition metal ion binding

ERVK-6 MBTD1 MYCBP2 ERVK-7 ERVK-10 TRIM14 USP51 SF3A3 ERVK-19 POLR1B MMP2 DMD ERVK-11 ALOX12 ALPG PITRM1 KDM5A CPB2 ACE2 ZFAND1 SYTL4 PRKACA ERVK-8 CYP4F22 PRKCB

4.55e-04118920325GO:0046914
GeneOntologyMolecularFunctionsmall GTPase binding

MYCBP2 NCF2 RABGAP1 ARHGAP44 RAF1 SYTL4 PRKACA DEPDC5 RIMS1 XPOT PLCE1

4.65e-0432120311GO:0031267
GeneOntologyMolecularFunctionendonuclease activity

ERVK-6 ERVK-7 ERVK-10 ERVK-11 ERVK-8 EXO1 RNASEH1

4.89e-041362037GO:0004519
GeneOntologyMolecularFunctionoxidoreductase activity

ACADL PYROXD1 NCF2 SQOR GPD1L HSD3B1 HSD3B2 ALDH1A3 ALDH9A1 CMAHP UTY ALOX12 KDM5A GPX4 AIFM1 MICAL2 CYP4F22 KCNAB3

8.59e-0476620318GO:0016491
GeneOntologyMolecularFunctionNAD binding

GPD1L HSD3B1 HSD3B2 ALDH1A3 ALDH9A1

8.87e-04732035GO:0051287
GeneOntologyMolecularFunctionnucleotidyltransferase activity

ERVK-6 ERVK-7 ERVK-10 POLR1B ERVK-11 ART3 ERVK-8

9.45e-041522037GO:0016779
GeneOntologyMolecularFunctionRNA polymerase II C-terminal domain phosphoserine binding

RTF1 SCAF8

1.01e-0352032GO:1990269
GeneOntologyMolecularFunctionDNA/RNA hybrid binding

POLR1B PRIM2

1.01e-0352032GO:0071667
GeneOntologyMolecularFunctionoxidoreductase activity, acting on NAD(P)H, oxygen as acceptor

NCF2 AIFM1 MICAL2

1.04e-03202033GO:0050664
GeneOntologyMolecularFunctionprotein serine kinase activity

TRPM6 SMG1 OBSCN BCR PIK3CG BUB1B RAF1 BRSK2 CASK PRKACA PRKCB

1.27e-0336320311GO:0106310
GeneOntologyMolecularFunction3-beta-hydroxy-delta5-steroid dehydrogenase (NAD+) activity

HSD3B1 HSD3B2

1.50e-0362032GO:0003854
GeneOntologyMolecularFunctioncarboxypeptidase activity

NAALAD2 CPB2 ACE2 CTSV

1.54e-03492034GO:0004180
GeneOntologyMolecularFunctionsteroid delta-isomerase activity

HSD3B1 HSD3B2

2.09e-0372032GO:0004769
GeneOntologyMolecularFunctionclathrin light chain binding

CLTCL1 CLTC

2.09e-0372032GO:0032051
GeneOntologyMolecularFunctionnuclease activity

ERVK-6 ERVK-7 ERVK-10 PAN2 ERVK-11 ERVK-8 EXO1 RNASEH1

2.57e-032312038GO:0004518
GeneOntologyMolecularFunctionflavin adenine dinucleotide binding

ACADL PYROXD1 SQOR AIFM1 MICAL2

2.73e-03942035GO:0050660
GeneOntologyMolecularFunction5alpha-androstane-3beta,17beta-diol dehydrogenase activity

HSD3B1 HSD3B2

2.77e-0382032GO:0047024
GeneOntologyMolecularFunction3-keto sterol reductase activity

HSD3B1 HSD3B2

2.77e-0382032GO:0000253
GeneOntologyBiologicalProcessDNA integration

ERVK-6 ERVK-7 ERVK-10 ERVK-11 ERVK-8

1.01e-07132015GO:0015074
GeneOntologyBiologicalProcessDNA recombination

ERVK-6 MBTD1 ERVK-7 MND1 ERVK-10 SMC5 USP51 ERVK-11 NIPBL KPNA2 MMS22L PELI1 ERVK-8 EXO1

1.62e-0536820114GO:0006310
DomainARM-type_fold

PDS5B SMG1 CLTCL1 PIK3CG PI4KA CLTC NIPBL KPNA2 NCAPD3 RALGAPA2 SCYL2 AP4E1 MROH2B CTNND1 CFAP69 XPOT

5.36e-0733919416IPR016024
DomainPyr_redox_2

PYROXD1 SQOR AIFM1 MICAL2

3.87e-05191944PF07992
DomainCH

SPTBN5 DMD PLS3 SYNE1 MICAL2 SMTNL2

5.77e-05651946SM00033
DomainSpectrin

SPTBN5 DMD SYNE1 CCDC141

8.56e-05231944PF00435
DomainACTININ_2

SPTBN5 DMD PLS3 SYNE1

8.56e-05231944PS00020
DomainACTININ_1

SPTBN5 DMD PLS3 SYNE1

8.56e-05231944PS00019
DomainActinin_actin-bd_CS

SPTBN5 DMD PLS3 SYNE1

8.56e-05231944IPR001589
DomainCH

SPTBN5 DMD PLS3 SYNE1 MICAL2 SMTNL2

8.77e-05701946PF00307
DomainHEAT_REPEAT

PDS5B SMG1 NIPBL NCAPD3 SCYL2 MROH2B

8.77e-05701946PS50077
Domain-

SPTBN5 DMD PLS3 SYNE1 MICAL2 SMTNL2

9.50e-057119461.10.418.10
DomainClathrin_H-chain_propeller_rpt

CLTCL1 CLTC

1.07e-0421942IPR022365
DomainClathrin-link

CLTCL1 CLTC

1.07e-0421942PF09268
Domain-

CLTCL1 CLTC

1.07e-04219422.130.10.110
DomainClathrin_heavy_chain

CLTCL1 CLTC

1.07e-0421942IPR016341
DomainRNaseH_domain

ERVK-6 RNASEH1

1.07e-0421942IPR002156
DomainClathrin_H-chain_propeller_N

CLTCL1 CLTC

1.07e-0421942IPR001473
DomainClathrin_H-chain_link/propller

CLTCL1 CLTC

1.07e-0421942IPR016025
DomainRNase_H

ERVK-6 RNASEH1

1.07e-0421942PF00075
DomainClathrin_propel

CLTCL1 CLTC

1.07e-0421942PF01394
DomainClathrin_H-chain_linker_core

CLTCL1 CLTC

1.07e-0421942IPR015348
DomainRNASE_H

ERVK-6 RNASEH1

1.07e-0421942PS50879
DomainCH

SPTBN5 DMD PLS3 SYNE1 MICAL2 SMTNL2

1.11e-04731946PS50021
Domain-

PDS5B NIPBL KPNA2 NCAPD3 SCYL2 AP4E1 MROH2B CTNND1 CFAP69 XPOT

1.13e-04222194101.25.10.10
DomainARM-like

PDS5B SMG1 NIPBL KPNA2 NCAPD3 SCYL2 AP4E1 MROH2B CTNND1 CFAP69 XPOT

1.26e-0427019411IPR011989
DomainCH-domain

SPTBN5 DMD PLS3 SYNE1 MICAL2 SMTNL2

1.29e-04751946IPR001715
Domain-

BCR PIK3CG PLCL1 MYOF SYTL4 PRKCB RIMS1 PLCE1

1.60e-0414819482.60.40.150
DomainSpectrin_repeat

SPTBN5 DMD SYNE1 CCDC141

2.19e-04291944IPR002017
DomainClathrin_H-chain_linker

CLTCL1 CLTC

3.20e-0431942IPR012331
DomainPellino

PELI2 PELI1

3.20e-0431942PF04710
DomainCLH

CLTCL1 CLTC

3.20e-0431942SM00299
DomainPellino_fam

PELI2 PELI1

3.20e-0431942IPR006800
DomainC2_dom

BCR PIK3CG PLCL1 MYOF SYTL4 PRKCB RIMS1 PLCE1

3.22e-041641948IPR000008
DomainSPEC

MCF2L2 SPTBN5 DMD SYNE1

3.23e-04321944SM00150
DomainSpectrin/alpha-actinin

MCF2L2 SPTBN5 DMD SYNE1

3.23e-04321944IPR018159
DomainC2

BCR PLCL1 MYOF SYTL4 PRKCB RIMS1 PLCE1

4.42e-041311947PF00168
DomainPI3/4_kinase_CS

SMG1 PIK3CG PI4KA

4.58e-04151943IPR018936
Domain-

SMG1 PIK3CG PI4KA

5.59e-041619431.10.1070.11
DomainPI3Kc

SMG1 PIK3CG PI4KA

5.59e-04161943SM00146
DomainC2

BCR PLCL1 MYOF SYTL4 PRKCB RIMS1 PLCE1

5.78e-041371947SM00239
DomainC2

BCR PLCL1 MYOF SYTL4 PRKCB RIMS1 PLCE1

7.15e-041421947PS50004
DomainPI3_PI4_kinase

SMG1 PIK3CG PI4KA

8.03e-04181943PF00454
DomainPI3_4_KINASE_1

SMG1 PIK3CG PI4KA

8.03e-04181943PS00915
DomainPI3_4_KINASE_2

SMG1 PIK3CG PI4KA

8.03e-04181943PS00916
DomainPI3/4_kinase_cat_dom

SMG1 PIK3CG PI4KA

8.03e-04181943IPR000403
DomainPI3_4_KINASE_3

SMG1 PIK3CG PI4KA

8.03e-04181943PS50290
Domain3Beta_HSD

HSD3B1 HSD3B2

1.57e-0361942PF01073
Domain3Beta_OHSteriod_DH/Estase

HSD3B1 HSD3B2

1.57e-0361942IPR002225
DomainKinase-like_dom

TRPM6 SMG1 OBSCN PIK3CG PI4KA BUB1B DMD RAF1 BRSK2 CASK SCYL2 PRKACA PRKCB ROS1

1.63e-0354219414IPR011009
Pubmed

Quantitation of HERV-K env gene expression and splicing in human breast cancer.

ERVK-6 ERVK-7 ERVK-18 ERVK-19

5.95e-095206412629516
Pubmed

Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.

CTTNBP2 MYCBP2 BCR SENP1 PTPRD MAGED2 PTPRS PI4KA ARHGAP44 CLTC MIOS ARC ANKRD28 PLCL1 NIPBL KDM5A SYNE1 SMC2 CASK PRKACA PRKCB RIMS1 CTNND1

1.70e-089632062328671696
Pubmed

KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.

MAP9 CTTNBP2 ACADL BCR JMY GPD1L PTPRS PI4KA ARHGAP44 CLTC MIOS PLCL1 FGG DMD ALDOA PLS3 RAF1 SYNE1 BRSK2 MYO18A RUFY3 CASK CUL5 MICAL2 PRKACA PRKCB RIMS1 CTNND1

3.12e-0814312062837142655
Pubmed

Defining the human deubiquitinating enzyme interaction landscape.

CTTNBP2 MYCBP2 AASDHPPT BCR PIK3CG NAF1 SF3A3 PAN2 MIOS ANKRD28 POLR1B MMP2 ALDH9A1 ALDOA GPX4 CASK CUL5 TGM3 SYTL4 PRIM2 PRKACA MPHOSPH9 CTNND1

3.71e-0810052062319615732
Pubmed

A revised nomenclature for transcribed human endogenous retroviral loci.

ERVK-6 ERVK-7 ERVK-10 ERVK-18 ERVK-19 ERVK-25 ERVK-11 ERVK-8

9.51e-0894206821542922
Pubmed

Genome-wide screening, cloning, chromosomal assignment, and expression of full-length human endogenous retrovirus type K.

ERVK-6 ERVK-18 ERVK-19

2.05e-073206310516026
Pubmed

A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.

SMG1 MBTD1 CTTNBP2 MYCBP2 ACO1 OBSCN CLTC ANKRD28 MMP2 ALDOA KDM5A SYNE1 CCDC141 XIRP2 PLCE1

3.29e-074972061523414517
Pubmed

Comparative interactome analysis of α-arrestin families in human and Drosophila.

BCR SQOR MFAP1 MAGED2 PTPRS PI4KA SF3A3 MIOS DMD SMC2 CTNND1 XPOT

4.25e-073132061238270169
Pubmed

Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans.

ERVK-6 ERVK-7 ERVK-10

8.16e-074206310469592
Pubmed

Human endogenous retrovirus K10: expression of Gag protein and detection of antibodies in patients with seminomas.

ERVK-6 ERVK-10 ERVK-19

8.16e-07420637983737
Pubmed

Network organization of the human autophagy system.

RABGAP1 MAGED2 PIK3CG CLTC ALDH9A1 NRBF2 DNAAF4 BRSK2 TGM3 XIRP2 CTNND1 BECN1 XPOT

2.39e-064372061320562859
Pubmed

Expression patterns of transcribed human endogenous retrovirus HERV-K(HML-2) loci in human tissues and the need for a HERV Transcriptome Project.

ERVK-10 ERVK-18 ERVK-25 ERVK-11

3.43e-0618206418664271
Pubmed

Ontogeny of mouse Sertoli, Leydig and peritubular myoid cells from embryonic day 10 to adulthood.

PECAM1 HSD3B1 HSD3B2

4.04e-066206335317954
Pubmed

Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.

TRPM6 PDS5B UGGT1 TRIM14 MAGED2 PI4KA CLTC SF3A3 ALDOA NIPBL PLS3 KPNA2 NCAPD3 PITRM1 DNAJC8 SYNE1 SMC2 TSFM TGM3 AIFM1 PRKACA PLPBP CTNND1 XPOT

4.45e-0614252062430948266
Pubmed

In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.

PDS5B SMG1 MAP9 CLTCL1 PYROXD1 CES1 UGGT1 MFAP1 MAGED2 CLTC DMD DNAH8 NIPBL KDM5A SYNE1 MYO18A SMC2 PHF20L1 TNN SAP30BP PRKACA RIMS1 CFAP69 UTP14C

5.44e-0614422062435575683
Pubmed

A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling.

UGGT1 AASDHPPT BCR TRIM14 PTPN6 PTPRD PTPRS SF3A3 ANKRD28 DMD ALDH9A1 PLS3 RAF1 NCAPD3 PITRM1 GPX4 SMC2 CASK XPOT

6.20e-069742061928675297
Pubmed

Novel effects of chromosome Y on cardiac regulation, chromatin remodeling, and neonatal programming in male mice.

HSD3B1 HSD3B2 UTY

7.04e-067206324105479
Pubmed

Myeloid cells are capable of synthesizing aldosterone to exacerbate damage in muscular dystrophy.

HSD3B1 HSD3B2 DMD

1.12e-058206327798095
Pubmed

Testosterone levels influence mouse fetal Leydig cell progenitors through notch signaling.

PECAM1 HSD3B1 HSD3B2

1.12e-058206323467742
Pubmed

Cathepsin proteases have distinct roles in trophoblast function and vascular remodelling.

PECAM1 EDIL3 CTSV

1.12e-058206318776147
Pubmed

Proteomic analysis of NMDA receptor-adhesion protein signaling complexes.

CLTC ARC RAF1 PRKACA PRKCB CTNND1

1.27e-0586206610862698
Pubmed

The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis.

PDS5B MYCBP2 MED14 SMC5 CENPP MAGED2 MIOS POLR1B KPNA2 NCAPD3 NRBF2 MYO18A SMC2 AIFM1 EXO1 BECN1

1.35e-057592061635915203
Pubmed

An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.

MYCBP2 BCR MFAP1 MAGED2 NAF1 ARHGAP44 SF3A3 PAN2 MIOS ANKRD28 PLS3 RAF1 PITRM1 DNAJC8 DNAAF4 CRTC1 SMC2 SCYL2 CEP44 PRKACA CTSV EDRF1

1.36e-0513212062227173435
Pubmed

Using an in situ proximity ligation assay to systematically profile endogenous protein-protein interactions in a pathway network.

PECAM1 BCR FZR1 PIK3CG CLTC BUB1B MMP2 FGG RAF1 PRKACA PRKCB

1.49e-053712061125241761
Pubmed

The transcription factor GATA4 is required for follicular development and normal ovarian function.

PECAM1 GDF9 HSD3B1 HSD3B2

1.61e-0526206423769843
Pubmed

Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.

MYCBP2 UGGT1 PTPN6 PTPRD PTPRS PI4KA CLTC MIOS ANKRD28 DMD KPNA2 VEZT CASK AIFM1 PRIM2 PRKACA MPHOSPH9 CTNND1 XPOT

1.74e-0510492061927880917
Pubmed

The regulation of Sox9 gene expression by the GATA4/FOG2 transcriptional complex in dominant XX sex reversal mouse models.

PECAM1 HSD3B1 HSD3B2

2.38e-0510206317540364
Pubmed

A protein interaction landscape of breast cancer.

ACO1 UGGT1 BPIFB1 SQOR GPD1L PI4KA CLTC ANKRD28 RAF1 MYO18A SLC7A2 SCUBE2 MICAL2 CTNND1

2.85e-056342061434591612
Pubmed

Proplatelet formation of megakaryocytes is triggered by autocrine-synthesized estradiol.

HSD3B1 HSD3B2

3.49e-052206214665668
Pubmed

Visualization of SHP-1-target interaction.

PTPN6 ROS1

3.49e-052206215456853
Pubmed

Serum Antibodies to N-Glycolylneuraminic Acid Are Elevated in Duchenne Muscular Dystrophy and Correlate with Increased Disease Pathology in Cmah-/-mdx Mice.

DMD CMAHP

3.49e-052206234294193
Pubmed

A human-specific deletion in mouse Cmah increases disease severity in the mdx model of Duchenne muscular dystrophy.

DMD CMAHP

3.49e-052206220668298
Pubmed

Muscle CD31(-) CD45(-) side population cells promote muscle regeneration by stimulating proliferation and migration of myoblasts.

MMP2 DMD

3.49e-052206218669618
Pubmed

Structure-function relationships of 3 beta-hydroxysteroid dehydrogenase: contribution made by the molecular genetics of 3 beta-hydroxysteroid dehydrogenase deficiency.

HSD3B1 HSD3B2

3.49e-05220629029734
Pubmed

The multiple murine 3 beta-hydroxysteroid dehydrogenase isoforms: structure, function, and tissue- and developmentally specific expression.

HSD3B1 HSD3B2

3.49e-05220629029733
Pubmed

Characterization of human 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4-isomerase gene and its expression in mammalian cells.

HSD3B1 HSD3B2

3.49e-05220622243100
Pubmed

Deficiency of SHP-1 protein-tyrosine phosphatase activity results in heightened osteoclast function and decreased bone density.

PTPN6 CSF1

3.49e-052206210393854
Pubmed

Structure/function relationships responsible for the kinetic differences between human type 1 and type 2 3beta-hydroxysteroid dehydrogenase and for the catalysis of the type 1 activity.

HSD3B1 HSD3B2

3.49e-052206212205101
Pubmed

Regulation of Bcr-Abl-induced SAP kinase activity and transformation by the SHPTP1 protein tyrosine phosphatase.

BCR PTPN6

3.49e-05220629788431
Pubmed

Cyclophosphamide-induced GPX4 degradation triggers parthanatos by activating AIFM1.

GPX4 AIFM1

3.49e-052206235339754
Pubmed

Immunolocalization of murine type VI 3β-hydroxysteroid dehydrogenase in the adrenal gland, testis, skin, and placenta.

HSD3B1 HSD3B2

3.49e-052206224075909
Pubmed

Peptide-conjugated phosphodiamidate oligomer-mediated exon skipping has benefits for cardiac function in mdx and Cmah-/-mdx mouse models of Duchenne muscular dystrophy.

DMD CMAHP

3.49e-052206229912990
Pubmed

Genomic stability and tumour suppression by the APC/C cofactor Cdh1.

FZR1 EDIL3

3.49e-052206218552834
Pubmed

Convergent regulation of skeletal muscle Ca2+ channels by dystrophin, the actin cytoskeleton, and cAMP-dependent protein kinase.

DMD PRKACA

3.49e-052206215753322
Pubmed

High carrier frequency of a nonsense p.Trp230* variant in HSD3B2 gene in Ossetians.

HSD3B1 HSD3B2

3.49e-052206237274334
Pubmed

Multiple forms of mouse 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4 isomerase and differential expression in gonads, adrenal glands, liver, and kidneys of both sexes.

HSD3B1 HSD3B2

3.49e-05220621924345
Pubmed

Effects of water restriction on gene expression in mouse renal medulla: identification of 3betaHSD4 as a collecting duct protein.

HSD3B1 HSD3B2

3.49e-052206216478974
Pubmed

Aberrant regulation of bone trace elements in motheaten and osteopetrosis mutant mice.

PTPN6 CSF1

3.49e-05220629593582
Pubmed

Expression of human endogenous retrovirus type K envelope glycoprotein in insect and mammalian cells.

ERVK-6 ERVK-19

3.49e-05220629060628
Pubmed

Cmah-dystrophin deficient mdx mice display an accelerated cardiac phenotype that is improved following peptide-PMO exon skipping treatment.

DMD CMAHP

3.49e-052206230281092
Pubmed

Shortage of dNTPs underlies altered replication dynamics and DNA breakage in the absence of the APC/C cofactor Cdh1.

FZR1 EDIL3

3.49e-052206228604743
Pubmed

Universal phosphatase-coupled glycosyltransferase assay.

POGLUT1 ST6GAL1

3.49e-052206221081508
Pubmed

Equine P450 cholesterol side-chain cleavage and 3 beta-hydroxysteroid dehydrogenase/delta(5)-delta(4) isomerase: molecular cloning and regulation of their messenger ribonucleic acids in equine follicles during the ovulatory process.

HSD3B1 HSD3B2

3.49e-052206211133676
Pubmed

Esterase genetics in Mus musculus: expression, linkage, and polymorphism of locus Es-2.

CES1 CSF1

3.49e-05220625372803
Pubmed

Matrix metalloproteinase-2 ablation in dystrophin-deficient mdx muscles reduces angiogenesis resulting in impaired growth of regenerated muscle fibers.

MMP2 DMD

3.49e-052206221320869
Pubmed

Joint effect of HSD3B1 and HSD3B2 genes is associated with hereditary and sporadic prostate cancer susceptibility.

HSD3B1 HSD3B2

3.49e-052206211912155
Pubmed

Association of the variations in the HSD3β gene with primary aldosteronism.

HSD3B1 HSD3B2

3.49e-052206224006038
Pubmed

Structure and expression of a new complementary DNA encoding the almost exclusive 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4-isomerase in human adrenals and gonads.

HSD3B1 HSD3B2

3.49e-05220621944309
Pubmed

Extrinsic sialylation is dynamically regulated by systemic triggers in vivo.

CMAHP ST6GAL1

3.49e-052206228717006
Pubmed

The mouse 3 beta-hydroxysteroid dehydrogenase multigene family includes two functionally distinct groups of proteins.

HSD3B1 HSD3B2

3.49e-05220627491113
Pubmed

The second catalytic domain of protein tyrosine phosphatase delta (PTP delta) binds to and inhibits the first catalytic domain of PTP sigma.

PTPRD PTPRS

3.49e-05220629566880
Pubmed

APC/C(Cdh1) targets brain-specific kinase 2 (BRSK2) for degradation via the ubiquitin-proteasome pathway.

FZR1 BRSK2

3.49e-052206223029325
Pubmed

Expression of 3beta-hydroxysteroid dehydrogenase type I and type VI isoforms in the mouse testis during development.

HSD3B1 HSD3B2

3.49e-052206210103023
Pubmed

Cyclic AMP blocks cell growth through Raf-1-dependent and Raf-1-independent mechanisms.

RAF1 PRKACA

3.49e-052206211997508
Pubmed

Human 3beta-hydroxysteroid dehydrogenase types 1 and 2: Gene sequence variation and functional genomics.

HSD3B1 HSD3B2

3.49e-052206217689071
Pubmed

Interferon-alpha-induced endogenous superantigen. a model linking environment and autoimmunity.

ERVK-6 ERVK-18

3.49e-052206211672541
Pubmed

VACM-1, a cullin gene family member, regulates cellular signaling.

CUL5 PRKACA

3.49e-052206210898738
Pubmed

Phosphatidylinositol-3 kinase activity is regulated by BCR/ABL and is required for the growth of Philadelphia chromosome-positive cells.

BCR PIK3CG

3.49e-05220627606002
Pubmed

Chaperones rejuvenate folding and activity of 3-β hydroxysteroid dehydrogenase 2.

HSD3B1 HSD3B2

3.49e-052206223485106
Pubmed

Angiotensin II-mediated oxidative stress and inflammation mediate the age-dependent cardiomyopathy in ACE2 null mice.

PIK3CG ACE2

3.49e-052206217499227
Pubmed

Down-regulating Myoferlin inhibits the vasculogenic mimicry of melanoma via decreasing MMP-2 and inducing mesenchymal-to-epithelial transition.

MMP2 MYOF

3.49e-052206229164766
Pubmed

Structure/function of the inhibition of human 3beta-hydroxysteroid dehydrogenase type 1 and type 2 by trilostane.

HSD3B1 HSD3B2

3.49e-052206218524572
Pubmed

Regulation of 3beta-hydroxysteroid dehydrogenase type 1 and type 2 gene expression and function in the human ovarian surface epithelium by cytokines.

HSD3B1 HSD3B2

3.49e-052206219414525
Pubmed

3beta-Hydroxysteroid dehydrogenases and pre-receptor steroid metabolism in the human ovarian surface epithelium.

HSD3B1 HSD3B2

3.49e-052206218778748
Pubmed

Assignment of homologous genes, Peli1/PELI1 and Peli2/PELI2, for the Pelle adaptor protein Pellino to mouse chromosomes 11 and 14 and human chromosomes 2p13.3 and 14q21, respectively, by physical and radiation hybrid mapping.

PELI2 PELI1

3.49e-052206211306823
Pubmed

3β-Hydroxysteroid dehydrogenase isoforms in human aldosterone-producing adenoma.

HSD3B1 HSD3B2

3.49e-052206225458695
Pubmed

A novel nonstop mutation in the stop codon and a novel missense mutation in the type II 3beta-hydroxysteroid dehydrogenase (3beta-HSD) gene causing, respectively, nonclassic and classic 3beta-HSD deficiency congenital adrenal hyperplasia.

HSD3B1 HSD3B2

3.49e-052206212050213
Pubmed

Immunohistochemical localization of the 11 beta-hydroxysteroid dehydrogenase type II enzyme in human kidney and placenta.

HSD3B1 HSD3B2

3.49e-05220627608280
Pubmed

The protein-tyrosine phosphatase SHP-1 binds to and dephosphorylates p120 catenin.

PTPN6 CTNND1

3.49e-052206210835420
Pubmed

Association of HSD3B1 and HSD3B2 gene polymorphisms with essential hypertension, aldosterone level, and left ventricular structure.

HSD3B1 HSD3B2

3.49e-052206220660004
Pubmed

Low-dose radiation-induced demethylation of 3β-HSD participated in the regulation of testosterone content.

HSD3B1 HSD3B2

3.49e-052206234550611
Pubmed

Modulation of proteoglycan receptor PTPσ enhances MMP-2 activity to promote recovery from multiple sclerosis.

PTPRS MMP2

3.49e-052206230297691
Pubmed

The hormonal phenotype of Nonclassic 3 beta-hydroxysteroid dehydrogenase (HSD3B) deficiency in hyperandrogenic females is associated with insulin-resistant polycystic ovary syndrome and is not a variant of inherited HSD3B2 deficiency.

HSD3B1 HSD3B2

3.49e-052206214764797
Pubmed

Three populations of adult Leydig cells in mouse testes revealed by a novel mouse HSD3B1-specific rat monoclonal antibody.

HSD3B1 HSD3B2

3.49e-052206230851938
Pubmed

Characterization of a second human clathrin heavy chain polypeptide gene (CLH-22) from chromosome 22q11.

CLTCL1 CLTC

3.49e-05220628733129
Pubmed

The murine 3 beta-hydroxysteroid dehydrogenase multigene family: structure, function and tissue-specific expression.

HSD3B1 HSD3B2

3.49e-05220627626443
Pubmed

Alpha2,6-sialic acid on platelet endothelial cell adhesion molecule (PECAM) regulates its homophilic interactions and downstream antiapoptotic signaling.

PECAM1 ST6GAL1

3.49e-052206220048157
Pubmed

CHC22 and CHC17 clathrins have distinct biochemical properties and display differential regulation and function.

CLTCL1 CLTC

3.49e-052206229097553
Pubmed

Evolutionary relationships within a subgroup of HERV-K-related human endogenous retroviruses.

ERVK-6 ERVK-19

3.49e-05220629460924
Pubmed

A novel mouse kidney 3 beta-hydroxysteroid dehydrogenase complementary DNA encodes a 3-ketosteroid reductase instead of a 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4-isomerase.

HSD3B1 HSD3B2

3.49e-05220628145763
Pubmed

MMP-2-mediated Scube2 degradation promotes blood-brain barrier disruption by blocking the interaction between astrocytes and endothelial cells via inhibiting Sonic hedgehog pathway during early cerebral ischemia.

MMP2 SCUBE2

3.49e-052206238148633
Pubmed

ACE2 is augmented in dystrophic skeletal muscle and plays a role in decreasing associated fibrosis.

DMD ACE2

3.49e-052206224695436
Pubmed

The clathrin heavy chain isoform CHC22 functions in a novel endosomal sorting step.

CLTCL1 CLTC

3.49e-052206220065094
Pubmed

Regional chromosomal assignment of human 3-beta-hydroxy-5-ene steroid dehydrogenase to 1p13.1 by non-isotopic in situ hybridisation.

HSD3B1 HSD3B2

3.49e-05220622066113
Pubmed

Expression of multiple forms of 3 beta-hydroxysteroid dehydrogenase in the mouse liver during fetal and postnatal development.

HSD3B1 HSD3B2

3.49e-05220628647315
Pubmed

Differences in substrate and inhibitor kinetics of human type 1 and type 2 3beta-hydroxysteroid dehydrogenase are explained by the type 1 mutant, H156Y.

HSD3B1 HSD3B2

3.49e-052206212530651
Pubmed

Isolation and characterization of several members of the murine Hsd3b gene family.

HSD3B1 HSD3B2

3.49e-05220628924213
Pubmed

Isolation of a new mouse 3beta-hydroxysteroid dehydrogenase isoform, 3beta-HSD VI, expressed during early pregnancy.

HSD3B1 HSD3B2

3.49e-05220629075693
Pubmed

Homocysteine stimulates phosphorylation of NADPH oxidase p47phox and p67phox subunits in monocytes via protein kinase Cbeta activation.

NCF2 PRKCB

3.49e-052206216626305
Pubmed

Elevated MMP2 abundance and activity in mdx mice are alleviated by prenatal taurine supplementation.

MMP2 DMD

3.49e-052206232208990
InteractionVASP interactions

BCR JMY BUB1B SF3A3 ANKRD28 NRBF2 PITRM1 CRTC1 SCYL2 XIRP2 PRKACA MPHOSPH9 FYB1

7.64e-0629419913int:VASP
InteractionSRRT interactions

SMG1 SAMD9 CES1 SMC5 SQOR FZR1 MAGED2 POLR1B ALDH1A3 DNAH8 KPNA2 RAF1 ACE2 TGM3

7.67e-0634019914int:SRRT
InteractionARRDC3 interactions

BCR SQOR MFAP1 MAGED2 PTPRS PI4KA SF3A3 MIOS DMD SMC2 CTNND1

1.47e-0522419911int:ARRDC3
Cytoband11p15.3

C11orf16 SCUBE2 MICAL2

1.10e-0421205311p15.3
GeneFamilyPellino E3 ubiquitin protein ligases

PELI2 PELI1

1.33e-0431212676
CoexpressionGABRIELY_MIR21_TARGETS

MYCBP2 TLCD4 UGGT1 RABGAP1 SMC5 RTF1 ANKRD28 DMD NIPBL PELI1 ST6GAL1 RUFY3 PHF20L1

3.41e-0728919813M2196
CoexpressionGSE12366_GC_VS_NAIVE_BCELL_UP

RABGAP1 MND1 BUB1B KPNA2 NCAPD3 VEZT SMC2 CD81 MPHOSPH9 EDRF1

2.86e-0619819810M3168
CoexpressionNAKAYA_B_CELL_FLUMIST_AGE_18_50YO_7DY_DN

CES1 PECAM1 NCF2 MFAP1 PTPRS PI4KA NIPBL SYNE1 RUFY3 TSFM AP4E1 RNASEH1 UTP14C

1.18e-0539919813M40939
CoexpressionLAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_SMALL_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP

MAP9 MED14 SMC5 SENP1 BUB1B ARC ANKRD28 KPNA2 NCAPD3 MMS22L BRSK2 SMC2 RUFY3 KIF20A PRIM2 EXO1 PRKCB

1.76e-0568019817MM456
CoexpressionGSE37416_0H_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_UP

SAMD9 BCR ALDH9A1 KPNA2 NRBF2 SYNE1 PHF20L1 MICAL2 FYB1

2.01e-051971989M5351
CoexpressionGSE20727_CTRL_VS_ROS_INH_AND_DNFB_ALLERGEN_TREATED_DC_UP

MYCBP2 ITFG2 ACO1 POGLUT1 CD101 SF3A3 SEMA4D GPX4 ZFAND1

2.01e-051971989M9250
CoexpressionGSE12507_PDC_CELL_LINE_VS_IMMATUE_T_CELL_LINE_UP

GMDS HSD3B2 PLS3 KPNA2 ACE2 MYOF PRIM2 EXO1

2.23e-051531988M438
CoexpressionKAECH_NAIVE_VS_MEMORY_CD8_TCELL_UP

MBTD1 NCF2 SQOR PAN2 MIOS ST6GAL1 CASK PRKCB MPHOSPH9

2.27e-052001989M3020
CoexpressionFEVR_CTNNB1_TARGETS_DN

PDS5B CES1 AASDHPPT SQOR CENPP EHF BUB1B SF3A3 POLR1B DMD KPNA2 PITRM1 KIF20A PRIM2 EXO1

2.29e-0555519815M2343
CoexpressionDODD_NASOPHARYNGEAL_CARCINOMA_UP

SMG1 MBTD1 MND1 SENP1 POGLUT1 BUB1B SF3A3 PAN2 POLR1B DMD KPNA2 NCAPD3 VEZT SMC2 TSFM CASK KIF20A SCYL2 MICAL2 PRIM2 EXO1 PLPBP MPHOSPH9 RNASEH1 EDRF1 XPOT

2.33e-05140719826M14427
CoexpressionPARENT_MTOR_SIGNALING_UP

SAMD9 PECAM1 AASDHPPT PTPN6 PI4KA SLC25A38 KDM5A SYNE1 ST6GAL1 TSFM VPS13D AIFM1 PRIM2 DEPDC5 CTNND1

2.93e-0556719815M16909
CoexpressionNAKAYA_MYELOID_DENDRITIC_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_DN

MAP9 RTF1 GPD1L DMD SEMA4D KDM5A CASK NKAPD1 PRKACA MPHOSPH9

4.10e-0526919810M41203
CoexpressionHAMAI_APOPTOSIS_VIA_TRAIL_UP

PDS5B CTTNBP2 MYCBP2 PYROXD1 MFAP1 ARHGAP44 BUB1B CPLANE1 NIPBL PLS3 DNAJC8 L1TD1 SMC2 PHF20L1 FYB1 CTSV

4.20e-0565619816M18979
CoexpressionMEISSNER_NPC_HCP_WITH_H3K4ME2

TLCD4 BCORL1 MND1 TRIM14 KCNK2 ARC ALDH1A3 SEMA4D WDR31 BRSK2 SCUBE2 NEURL1 RIMS1

1.04e-0449319813M1951
CoexpressionMEISSNER_NPC_HCP_WITH_H3K4ME2

TLCD4 BCORL1 MND1 TRIM14 KCNK2 ARC ALDH1A3 SEMA4D WDR31 BRSK2 SCUBE2 NEURL1 RIMS1

1.29e-0450419813MM830
CoexpressionGSE16450_CTRL_VS_IFNA_12H_STIM_IMMATURE_NEURON_CELL_LINE_UP

ITFG2 GPD1L USP51 GMDS RALGAPA2 CASK VPS13D PRKCB

1.33e-041971988M7403
CoexpressionGSE12366_GC_VS_MEMORY_BCELL_UP

RABGAP1 PIK3CG DMD GALNT14 AFF2 KIF20A CD81 VGLL4

1.38e-041981988M3171
CoexpressionGSE15139_GMCSF_TREATED_VS_UNTREATED_NEUTROPHILS_DN

SMG1 SMC5 FZR1 KDM5A WDR31 TMEM87A FAM204A XPOT

1.42e-041991988M7099
CoexpressionGSE32533_WT_VS_MIR17_OVEREXPRESS_ACT_CD4_TCELL_UP

SMC5 NAF1 POLR1B CMAHP TSFM CUL5 CSF1 CD81

1.42e-041991988M8462
CoexpressionGSE360_L_DONOVANI_VS_B_MALAYI_HIGH_DOSE_DC_DN

MYCBP2 PECAM1 AASDHPPT BUB1B CMAHP SYNE1 VGLL4 UTP14C

1.42e-041991988M5201
CoexpressionGSE9650_NAIVE_VS_EFF_CD8_TCELL_UP

MBTD1 MYCBP2 PAN2 POLR1B PELI1 ST6GAL1 CASK CTSV

1.47e-042001988M5819
CoexpressionGSE12001_MIR223_KO_VS_WT_NEUTROPHIL_DN

TLCD4 SMC5 NAF1 ALDH9A1 TMEM87A ART3 AIFM1 EDRF1

1.47e-042001988M391
CoexpressionGSE9650_NAIVE_VS_MEMORY_CD8_TCELL_UP

MBTD1 PAN2 MIOS ST6GAL1 CASK PRKCB MPHOSPH9 CTSV

1.47e-042001988M5831
CoexpressionGSE41978_WT_VS_ID2_KO_AND_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_DN

BPIFB1 MFAP1 LRRC56 MMS22L MYO18A C11orf16 PHF20L1 ZNF746

1.47e-042001988M9548
CoexpressionGSE15735_2H_VS_12H_HDAC_INHIBITOR_TREATED_CD4_TCELL_UP

NCF2 RTF1 MYO18A ST6GAL1 RUFY3 MYOF CD81 DSEL

1.47e-042001988M7159
CoexpressionGSE30962_PRIMARY_VS_SECONDARY_ACUTE_LCMV_INF_CD8_TCELL_UP

MND1 CENPP CLTC BUB1B KPNA2 SMC2 KIF20A EXO1

1.47e-042001988M5041
CoexpressionGSE2585_CTEC_VS_MTEC_THYMUS_DN

PTPN6 PIK3CG MMP2 MMS22L CPB2 EDIL3 SLC7A2 FYB1

1.47e-042001988M6274
CoexpressionGSE22432_UNTREATED_VS_TGFB1_TREATED_COMMON_DC_PROGENITOR_DN

SQOR PTPN6 GPX4 MYO18A PRIM2 PRKACA PRKCB CD81

1.47e-042001988M7828
CoexpressionGSE20366_EX_VIVO_VS_HOMEOSTATIC_CONVERSION_NAIVE_CD4_TCELL_DN

ACO1 SQOR CENPP EHF KPNA2 CSF1 CD81 XPOT

1.47e-042001988M4326
CoexpressionLEE_DIFFERENTIATING_T_LYMPHOCYTE

MYCBP2 TRIM14 PIK3CG SEMA4D KDM5A PRKCB MPHOSPH9 FYB1

1.53e-042011988M2200
CoexpressionHE_LIM_SUN_FETAL_LUNG_C3_CYCLING_DEFINITIVE_ERYTHROBLAST

TLCD4 MND1 CENPP BUB1B SLC25A38 KPNA2 NCAPD3 SMC2 KIF20A EXO1 MPHOSPH9 ATG4D

1.73e-0445019812M45747
CoexpressionGSE4590_PRE_BCELL_VS_SMALL_PRE_BCELL_UP

BCORL1 TRIM14 MAGED2 PLCL1 ST6GAL1 PRKCB CD81

1.83e-041551987M6860
CoexpressionNAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_DN

MED14 BCR JMY NAF1 ANKRD28 PLCL1 RAF1 NRBF2 SCAF8 PELI2 RALGAPA2 PHF20L1 ZNF746 TBC1D23 EDRF1

2.19e-0468019815M41089
CoexpressionAtlasDevelopingKidney_e15.5_Medullary collecting duct_emap-28063_k-means-cluster#4_top-relative-expression-ranked_1000

SMG1 MYCBP2 MED14 RABGAP1 JMY CPLANE1 NCAPD3 KDM5A PELI1 CCDC141 CASK CUL5

6.60e-0626119812gudmap_developingKidney_e15.5_Medullary collecting duct_1000_k4
CoexpressionAtlasdev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_1000

FABP7 PTPRD BUB1B MMP2 UTY PLS3 MMS22L AFF2 ST6GAL1 CASK SCYL2 ACE2 GXYLT2 MYOF TGM3 SLC7A2 MICAL2 EXO1 HAPLN3 PRKCB PLCE1

3.24e-0582719821gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_1000
ToppCellE18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

BCR FAM162B FABP7 MAGED2 C1S NAALAD2 AFF2 ADAMTSL3 ART3 CD81 PLCE1

8.42e-1018819711a906c29e3fda22eecfec3e5cac706c417bf2b7a4
ToppCellfacs-Lung-nan-3m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

BCR FAM162B MAGED2 PLCL1 NAALAD2 AFF2 ST6GAL1 ADAMTSL3 ART3 KCNAB3

7.82e-0917919710d4a975d8ffa5e77fb5c0ec05bf9c8f843c77ce07
ToppCellfacs-Lung-nan-3m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

BCR FAM162B MAGED2 PLCL1 NAALAD2 AFF2 ST6GAL1 ADAMTSL3 ART3 KCNAB3

7.82e-09179197107078022e60faa86444f2a2c6eb9f767cc66b5cfa
ToppCellE17.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

BCR FAM162B FABP7 MAGED2 PLCL1 NAALAD2 ADAMTSL3 ART3 CD81 PLCE1

1.31e-081891971026cfe5b7e7f477f225f4e9f25f983f432f01e183
ToppCellE17.5-Mesenchymal-developing_mesenchymal_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

BCR FAM162B FABP7 MAGED2 PLCL1 NAALAD2 ADAMTSL3 ART3 CD81 PLCE1

1.38e-08190197102ab604d35456beba71c25511e0f819000e6642d2
ToppCellE18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

BCR FAM162B MAGED2 C1S NAALAD2 AFF2 ADAMTSL3 ART3 CD81 PLCE1

1.38e-0819019710951e067d14412db67dc3babcdf61e41717d7b429
ToppCellPND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

FAM162B FABP7 MAGED2 C1S DMD NAALAD2 AFF2 ADAMTSL3 ART3 CD81

1.68e-08194197106a4e7f1bf67bad94cd8c472e7c66798b0c25ba01
ToppCellE16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

FAM162B FABP7 MAGED2 C1S NAALAD2 AFF2 ADAMTSL3 ART3 PLCE1

7.07e-0817019791f994b690e881106a5d54b3080ccce6260bc3ac5
ToppCellPND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

FAM162B MAGED2 C1S DMD NAALAD2 AFF2 ADAMTSL3 ART3 EXO1

7.82e-08172197903a0aff6b7971093a4347b5ed12546d78374c56f
ToppCellpdx-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)

PDS5B MND1 CENPP BUB1B NCAPD3 MMS22L PRIM2 EXO1 MPHOSPH9

1.83e-071901979d06ee5f89f1cec8db6897fe3b2a890a07cd3697b
ToppCellPND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

FAM162B MAGED2 C1S DMD NAALAD2 AFF2 ADAMTSL3 ART3 CD81

1.83e-0719019791004e89d99c9d46c78b7d3532d8d4aadb81a96fd
ToppCellPND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

FAM162B MAGED2 C1S DMD NAALAD2 AFF2 ADAMTSL3 ART3 CD81

1.83e-07190197910b02c62e72bfea9767e3e751011436925da823e
ToppCellPND14-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

FAM162B MAGED2 C1S CD302 NAALAD2 AFF2 ADAMTSL3 ART3 CD81

2.00e-071921979158cc5736f154da1cb3186ffbf186eae10483e48
ToppCellE16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

FAM162B FABP7 MAGED2 C1S NAALAD2 AFF2 ADAMTSL3 ART3 CD81

2.00e-071921979430ef714bf2544d32f3fd96a55af010f79aa9be0
ToppCellPND14-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

FAM162B MAGED2 C1S CD302 NAALAD2 AFF2 ADAMTSL3 ART3 CD81

2.00e-071921979f4ff62ac9c53eafbe917706de9af8b2d4bded4d4
ToppCellnucseq-Epithelial-Epithelial_Alveolar-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

ACADL PTPRD SYNE1 CCDC141 RUFY3 SLC7A2 MICAL2 ROS1 LRRC36

2.09e-071931979f3cc7cfdbc164a4ed42f87647111522b7d393bcb
ToppCellnucseq-Epithelial-Epithelial_Alveolar-AT2-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

ACADL PTPRD SYNE1 CCDC141 RUFY3 SLC7A2 MICAL2 ROS1 LRRC36

2.09e-071931979fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf
ToppCellPND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

BCR FAM162B FABP7 MAGED2 C1S NAALAD2 AFF2 ART3 CD81

2.28e-0719519797a32a8535c29b819dacba901d0658280a2631c94
ToppCellPND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

BCR FAM162B FABP7 MAGED2 C1S NAALAD2 AFF2 ART3 CD81

2.28e-0719519794a5d2f62aad5817d077177bf8b4ff0e46d3b8d97
ToppCellPND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

BCR FAM162B FABP7 MAGED2 C1S NAALAD2 AFF2 ART3 CD81

2.38e-0719619796708026bafd19c35c5c4e81911344d36a0f508cd
ToppCellLPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

PTPRD C1S CD302 MMP2 ALDH1A3 SYNE1 MYOF SYTL4 CFAP69

2.48e-071971979fdb92985f7df0c280b87d3e43c2394e70786a2c7
ToppCelldroplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MYCBP2 PTPRD C1S CD302 MMP2 NAALAD2 AFF2 EDIL3 SCUBE2

2.48e-071971979cfd4cc5fb8d7a60dd5c0d2a1a7bad7ba38c19d40
ToppCellmedial-2-Epithelial-Alveolar_Epithelial_Type_2|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

ACADL EHF CMAHP CPB2 CCDC141 SLC7A2 MICAL2 ROS1 LRRC36

2.59e-071981979102a4cbb138adbfba11ed955420095daa098532f
ToppCellmedial-Epithelial-Alveolar_Epithelial_Type_2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

ACADL EHF CMAHP CPB2 CCDC141 SLC7A2 MICAL2 ROS1 LRRC36

2.59e-07198197953e5d76831d70b9a476f3ef3a81e13eda974d543
ToppCellmedial-Epithelial-Alveolar_Epithelial_Type_2-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

ACADL EHF CMAHP CPB2 CCDC141 SLC7A2 MICAL2 ROS1 LRRC36

2.59e-0719819797caeed2d5dc78866023c8f38edcec9886baa9f2c
ToppCellLPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

PTPRD C1S CD302 MMP2 NAALAD2 SYNE1 MYOF SYTL4 CD81

2.70e-07199197930d3e8c0681ec11f86dd38c5f48d21187a1b4f90
ToppCelldistal-2-Epithelial-Alveolar_Epithelial_Type_2|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

ACADL EHF CMAHP CPB2 CCDC141 SLC7A2 MICAL2 ROS1 LRRC36

2.70e-07199197921b44031bc5182ee23ba5e206042b2e5e4ee0c3c
ToppCellLPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type

MYCBP2 PTPRD C1S CD302 MMP2 MYOF SCUBE2 SYTL4 CD81

2.82e-072001979a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2
ToppCell(24)_B_cell_cycling|World / shred on Cell_type and subtype

CLTCL1 MND1 BUB1B DMD ALDH1A3 AFF2 SMC2 KIF20A EXO1

3.07e-072021979a7c9b6b173701348ba35fbb975e0bdd3c1f1d5fe
ToppCellLPS-antiTNF-Endothelial-Endothelial-FOXM1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

CENPP BUB1B NCAPD3 MMS22L SMC2 KIF20A EXO1 MPHOSPH9

6.81e-0716319785285318c52aa31c9b22dc2ffff078e32e408604d
ToppCellNS-critical-d_0-4-Epithelial-unknown_epithelial|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

NT5DC1 SPTBN5 ARC ACE2 GXYLT2 SYTL4 RIMS1 KCNAB3

7.82e-071661978dd02bbe4af609c6348dc92417254f4740f2900a8
ToppCellLPS-IL1RA+antiTNF-Endothelial-Endothelial-FOXM1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

CENPP BUB1B KPNA2 NCAPD3 MMS22L SMC2 KIF20A EXO1

8.95e-071691978e0607af8ae8609d43e26ff2a2cab92650bfcd5b7
ToppCellSubstantia_nigra-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2|Substantia_nigra / BrainAtlas - Mouse McCarroll V32

MND1 BUB1B NAALAD2 KIF20A ACE2 ART3 HAPLN3

1.09e-061201977e60b74758c8290919b326904ad841962256b72ec
ToppCellSubstantia_nigra-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2-MURAL_Mural.Rgs5Acta2.Kcnj8_(Mural.Rgs5Acta2.Kcnj8)-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32

MND1 BUB1B NAALAD2 KIF20A ACE2 ART3 HAPLN3

1.09e-0612019773e1ae5a5422729d484a90d72f779833fe3473fa8
ToppCellSubstantia_nigra-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2-MURAL_Mural.Rgs5Acta2.Kcnj8_(Mural.Rgs5Acta2.Kcnj8)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32

MND1 BUB1B NAALAD2 KIF20A ACE2 ART3 HAPLN3

1.09e-06120197724d5e86931a857bb87684392172bf04294a1a46a
ToppCellfacs-Lung-3m-Mesenchymal-myofibroblast-pericyte_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

MND1 BCR FAM162B MAGED2 PLCL1 AFF2 ADAMTSL3 ART3

1.16e-0617519782a53d4f140d5ab096efe8118d8aa351db7838b49
ToppCellfacs-Lung-3m-Mesenchymal-myofibroblast-pericyte_cell-pericyte|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

MND1 BCR FAM162B MAGED2 PLCL1 AFF2 ADAMTSL3 ART3

1.16e-061751978fb91a45763e4c48d993094a13088ffc19f1e2574
ToppCelldroplet-Lung-3m-Mesenchymal-myofibroblast-pericyte_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

BCR FAM162B MAGED2 PLCL1 NAALAD2 AFF2 ADAMTSL3 ART3

1.22e-061761978f931192e3cc65414e2245354f443473696cc7ce8
ToppCelldroplet-Lung-3m-Mesenchymal-myofibroblast-pericyte_cell-pericyte|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

BCR FAM162B MAGED2 PLCL1 NAALAD2 AFF2 ADAMTSL3 ART3

1.22e-061761978e2b59a904c5c8f9c88e1e63788e9b6485f22edd0
ToppCellPND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

FAM162B BUB1B AFF2 SMC2 ADAMTSL3 KIF20A ART3 HAPLN3

1.27e-0617719782b63f0529ef73e0eede9b7ef1f08b0a0426a9c82
ToppCellControl-Epithelial_cells-AT2|Control / group, cell type (main and fine annotations)

ACADL PTPRD SYNE1 CCDC141 SLC7A2 MICAL2 ROS1 LRRC36

1.44e-061801978198b19e7910b4a8cc7e820c525ab357c7f99f578
ToppCellfacs-Large_Intestine-Proximal-3m-Epithelial-secretory_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

GDF9 USP51 BUB1B PLS3 NCAPD3 KIF20A SYTL4 DBX1

1.50e-061811978b203b616584cdbd0bbb0e382b2916d0bd49d3526
ToppCellP28-Mesenchymal-mesenchymal_fibroblast|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

PTPRD C1S CD302 MMP2 SCUBE2 CD81 CTSV SMTNL2

1.50e-061811978091e7975badd1ffa463a8ec87908be20781ecfd6
ToppCellfacs-Large_Intestine-Proximal-3m-Epithelial-Reg4/cKit+_deep_crypt_secretory_cells_(Distal)|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

GDF9 USP51 BUB1B PLS3 NCAPD3 KIF20A SYTL4 DBX1

1.50e-061811978c748c16fd20d1949d33ff6290dc9d9016c4dc86c
ToppCellCOPD-Epithelial-ATII|World / Disease state, Lineage and Cell class

ACADL FGG CMAHP SYNE1 CCDC141 SLC7A2 ROS1 LRRC36

1.63e-0618319788e9aab4eeec2e282c2cab9bfca6dbf40d660c7b9
ToppCelldroplet-Lung-30m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

TRPM6 CTTNBP2 MAGED2 ARHGAP44 MMP2 DMD MICAL2 SMTNL2

1.63e-061831978351d575339038bd4a66f408da518c567444208e8
ToppCelldroplet-Lung-30m-Mesenchymal-myofibroblast-pericyte_cell-pericyte|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

FAM162B MAGED2 C1S DMD NAALAD2 AFF2 ADAMTSL3 ART3

1.70e-0618419787128a2be291544d3df3ed6c80f21ddda8437dcba
ToppCellLPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

FAM162B PLCL1 DMD AFF2 ADAMTSL3 EDIL3 MYOF PLCE1

1.70e-061841978102b6f621a5b551e622f97b12d787c080b052a72
ToppCellP28-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

MND1 FAM162B MAGED2 NAALAD2 AFF2 ADAMTSL3 ART3 CD81

1.70e-06184197823c24ab5786af33d605bc445d06117b9da6c6331
ToppCelldroplet-Lung-30m-Mesenchymal-myofibroblast|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

FAM162B MAGED2 C1S DMD NAALAD2 AFF2 ADAMTSL3 ART3

1.70e-06184197855dde9c4eebac2a33788c1ff1d8fe312d150fad4
ToppCelldroplet-Lung-30m-Mesenchymal-myofibroblast-pericyte_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

FAM162B MAGED2 C1S DMD NAALAD2 AFF2 ADAMTSL3 ART3

1.70e-061841978d14238f7b0b55a4c8d7040bea854bd221a66ac30
ToppCellLPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

FAM162B PLCL1 DMD AFF2 ADAMTSL3 EDIL3 MYOF PLCE1

1.70e-061841978327ff3ac8d2fecdd5d242bdc34f0dfdb1c59a68b
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

MND1 CENPP BUB1B NCAPD3 SMC2 KIF20A PRIM2 EXO1

1.91e-061871978057569c9437219ecc396aa6e673b1178a2273837
ToppCellP28-Mesenchymal-developing_mesenchymal_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

MND1 FAM162B MAGED2 CD302 NAALAD2 ADAMTSL3 ART3 CD81

1.99e-061881978e7681efb4d2de7f1d8a89552fff76a829376bf1b
ToppCellCOPD-Epithelial-ATII|COPD / Disease state, Lineage and Cell class

ACADL EHF FGG CMAHP CCDC141 SLC7A2 ROS1 LRRC36

1.99e-061881978eb6d79d733b53f64ca615bb777c64ed456866549
ToppCellControl-Endothelial-Endothelial-FOXM1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

CENPP BUB1B KPNA2 NCAPD3 MMS22L SMC2 KIF20A EXO1

2.07e-0618919781e1499b062d9c647c8f38b0c4e0d871d159be5dd
ToppCellP03-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

BCR FAM162B MAGED2 NAALAD2 AFF2 ADAMTSL3 ART3 CD81

2.15e-061901978979b1476fd2692fde977ce56257315fcfc8a01d5
ToppCellPND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

FAM162B MAGED2 C1S CD302 NAALAD2 AFF2 ADAMTSL3 ART3

2.15e-0619019787fec459cd2ad12c2923a03d098289337c0a4c1d3
ToppCellP07-Mesenchymal-developing_mesenchymal_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

FAM162B MAGED2 NAALAD2 SMC2 ADAMTSL3 KIF20A ART3 CD81

2.24e-061911978ddbc5f97f2aef19be4ad93db4139876c939b848e
ToppCellCOVID-19-kidney-Proliferating_T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type

MND1 CENPP BUB1B NCAPD3 MMS22L SMC2 EXO1 PRKCB

2.24e-061911978bae388e0e9447d576e68465d73d8313ef6925ffa
ToppCelldroplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MYCBP2 PTPRD C1S CD302 MMP2 NAALAD2 AFF2 EDIL3

2.33e-06192197811088878043a6ff95ba1970361256a82e434b80a
ToppCellFibroblast-D_(Pericyte)|World / shred on cell class and cell subclass (v4)

FAM162B FABP7 MAGED2 PLCL1 NAALAD2 ADAMTSL3 ART3 CD81

2.33e-0619219788c13c351fcc3d88e8c2ffa017e71ff6272cc6fac
ToppCellfacs-Thymus-Flowthrough-3m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CENPP BUB1B KPNA2 NCAPD3 MMS22L SMC2 KIF20A EXO1

2.33e-061921978e8d47504b744040a762ec9b670a66cc060b2ae86
ToppCellPND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

FAM162B MAGED2 C1S DMD PLS3 NAALAD2 ART3 CD81

2.42e-06193197888916d9a7d831eb52848599917c04238f8f9812b
ToppCellhuman_hepatoblastoma-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)

MND1 CENPP BUB1B NCAPD3 MMS22L PRIM2 EXO1 MPHOSPH9

2.42e-0619319784b9fa2a4424f8abe63fa7bee78db93dda04ab15f
ToppCellnucseq-Epithelial-Epithelial_Alveolar|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

ACADL ARHGAP44 SYNE1 CCDC141 MICAL2 ST6GALNAC5 ROS1 CTNND1

2.51e-06194197853f3e49e91b1096f3226010e2de767efb490dfe4
ToppCellLPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

PTPRD PTPRS C1S MMP2 DMD SYNE1 MYOF SLC7A2

2.51e-0619419786e13549f697f7478b34fe71f7dd9d63c5d3db22e
ToppCellE15.5-Mesenchymal-developing_mesenchymal_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

FAM162B CENPP FZR1 MAGED2 BUB1B KPNA2 SMC2 KIF20A

2.51e-061941978d840c1949c328779426c9172e02da09e968f0567
ToppCellLPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

PTPRD PTPRS C1S MMP2 NAALAD2 SYNE1 SLC7A2 SCUBE2

2.51e-06194197860622bd2f75bfe4c37f721cb12f03dab33f2f58d
ToppCellCOVID-19_Mild-Non-classical_Monocyte|COVID-19_Mild / Disease condition and Cell class

PECAM1 PTPN6 MAGED2 PIK3CG L1TD1 MYOF NEURL1 CYP4F22

2.61e-061951978dd00facd20a661ef23fa7fd9a02ee377b8f2d1b9
ToppCellCOVID-19-T_cells-Cycling_NK/T_cells|COVID-19 / group, cell type (main and fine annotations)

MND1 CENPP BUB1B NCAPD3 MMS22L SMC2 EXO1 MPHOSPH9

2.61e-061951978764ed100c28d9bc93ee5ecabc5291c8f184d78da
ToppCellCOVID-19_Mild-Non-classical_Monocyte-|COVID-19_Mild / Disease condition and Cell class

PECAM1 PTPN6 MAGED2 PIK3CG L1TD1 MYOF NEURL1 CYP4F22

2.61e-0619519780295d9897830987eec74f51178e14fb0a83723dc
ToppCell3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

ACADL FGG SYNE1 CPB2 CCDC141 RUFY3 ROS1 LRRC36

2.71e-0619619787e5addaa844e66f8160e05858c341866a80aed23
ToppCellControl-Non-classical_Monocyte-|Control / Disease condition and Cell class

PECAM1 PTPN6 MAGED2 PIK3CG L1TD1 MYOF NEURL1 CYP4F22

2.71e-061961978b17ab094cdc7050c2997e24ed474779b5d6f6146
ToppCellControl-Non-classical_Monocyte|Control / Disease condition and Cell class

PECAM1 PTPN6 MAGED2 PIK3CG L1TD1 MYOF NEURL1 CYP4F22

2.71e-061961978404064ccfe2cb73df7a7f88aa65d86b97dcef9d4
ToppCellAT2_cells-HP_01|World / lung cells shred on cell class, cell subclass, sample id

C1S FGG CPB2 SLC7A2 SCUBE2 MICAL2 ROS1 LRRC36

2.82e-0619719788b5d4e1c33a57c899c51feb9a6f347232f8910a3
ToppCellCaecum-B_cell-B_cell_cycling|Caecum / Region, Cell class and subclass

CLTCL1 MND1 CENPP BUB1B GALNT14 KIF20A EXO1 CFAP69

2.93e-06198197861294fe99a5641ad359796022c3d038470076b3c
ToppCellCaecum-(2)_B_cell-(24)_B_cell_cycling|Caecum / shred on region, Cell_type, and subtype

CLTCL1 MND1 CENPP BUB1B GALNT14 KIF20A EXO1 CFAP69

2.93e-061981978568d47770cd20c6569ca84ea1eafde367642d68b
ToppCelldistal-Epithelial-Alveolar_Epithelial_Type_2-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

ACADL EHF CMAHP CCDC141 SLC7A2 MICAL2 ROS1 LRRC36

2.93e-061981978de5748c2b66ecc432974cf095ecd241369579f7c
ToppCellTracheal-NucSeq-Epithelial-Epi_airway_basal-Dividing_Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

MND1 CENPP BUB1B KPNA2 GALNT14 SMC2 KIF20A EXO1

2.93e-061981978f088badb90c6c2d916195f5649eda102119c9ac6
ToppCell(2)_B_cell-(24)_B_cell_cycling|(2)_B_cell / shred on Cell_type and subtype

CLTCL1 MND1 BUB1B ALDH1A3 AFF2 SMC2 KIF20A EXO1

3.04e-061991978d5a9a8a71c4de8cbcef947943f60838731bc640b
ToppCellLPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

MYCBP2 PTPRD C1S CD302 MMP2 SYNE1 MYOF SYTL4

3.04e-061991978a7dd94b172c973a131a6792f8ccd9bfe44d984ac
ToppCellLPS_only-Mesenchymal_fibroblastic|LPS_only / Treatment groups by lineage, cell group, cell type

MYCBP2 C1S CD302 MMP2 ALDH1A3 MYOF SYTL4 CD81

3.04e-061991978211c3a08f2d484ab7a3368006767289088f0d957
ToppCellLPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

PTPRD C1S CD302 MMP2 SYNE1 MYOF SYTL4 CD81

3.04e-061991978e1849505b92820a219c5a2c35492bdd55579fb48
ToppCellLPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

PTPRD C1S MMP2 ALDH1A3 SYNE1 MYOF SLC7A2 CFAP69

3.04e-0619919788b86c69aaf60feff53aa782559cfece7342a23de
ToppCellLPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

C1S CD302 MMP2 ALDH1A3 MYOF SCUBE2 SYTL4 CD81

3.04e-06199197838ed3bc7daa993d9edcf3e7834597ebb06dd24f8
ToppCellLPS_only-Mesenchymal_fibroblastic-Fibroblasts|LPS_only / Treatment groups by lineage, cell group, cell type

MYCBP2 C1S CD302 MMP2 ALDH1A3 MYOF SYTL4 CD81

3.04e-0619919781a0add79f4e34078b3475eb11c85a4234bda197c
ToppCellILEUM-non-inflamed-(8)_Fibroblast-(8)_Fibroblasts|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)

C1S CD302 MMP2 ALDH1A3 CRTC1 EDIL3 CSF1 CD81

3.04e-06199197856d72da6a5fab9cbb2975fe6f87a631debaba6a8
ToppCellLPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

PTPRD C1S CD302 MMP2 SYNE1 MYOF SCUBE2 SYTL4

3.15e-0620019789b0916d8d07ac2bf1739f7be5296bf77ffee6094
ToppCelldistal-3-Epithelial-Signaling_Alveolar_Epithelial_Type_2|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

CHIA ACADL EHF CPB2 CCDC141 SLC7A2 ROS1 LRRC36

3.15e-062001978a77087a393aad674d4aa457ca6c0077b0424053d
ToppCellLPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

PTPRD C1S CD302 MMP2 SYNE1 MYOF SYTL4 CD81

3.15e-062001978b79628fd1386aa9a3b0e9fa81def0bc100c3c073
ToppCellLPS_anti-TNF-Mesenchymal_fibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

PTPRD C1S CD302 MMP2 SYNE1 MYOF SYTL4 CD81

3.15e-06200197850ca6550998e461ef26dd670351060bd940765a8
ToppCellFetal_brain-organoid_Tanaka_cellReport-GW23-Stem_cells-Neuroepithelial_cell|GW23 / Sample Type, Dataset, Time_group, and Cell type.

MND1 EHF BUB1B DNAAF4 SMC2 CCDC141 KIF20A EXO1

3.15e-062001978c9c832f489629b8724501ddfede984b41a7b674d
ToppCellBiopsy_Other_PF-Immune-Proliferating_Macrophages|Biopsy_Other_PF / Sample group, Lineage and Cell type

MND1 CENPP BUB1B KPNA2 NCAPD3 SMC2 KIF20A EXO1

3.15e-06200197861473e8613f39a92002d5b631e6bd563735566e4
ToppCellParenchymal-NucSeq-Epithelial-Epi_alveolar-Dividing_AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

MND1 CENPP BUB1B NCAPD3 SMC2 KIF20A PRIM2 EXO1

3.15e-062001978af3dc76b4507bf4edd265169f5dfbbb8a19eb394
ToppCellFetal_brain-organoid_Tanaka_cellReport-GW23-Stem_cells|GW23 / Sample Type, Dataset, Time_group, and Cell type.

MND1 EHF BUB1B DNAAF4 SMC2 CCDC141 KIF20A EXO1

3.15e-062001978d7832ab1ed0ff0a6f7e3ac11b2095dc72c90af44
ToppCellLPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

PTPRD C1S CD302 MMP2 SYNE1 MYOF SYTL4 CD81

3.15e-0620019783bdba9612cd7c612b76aa9abecc4a6529aabfc1c
ToppCellLPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

PTPRD C1S CD302 MMP2 SYNE1 MYOF SYTL4 CD81

3.15e-06200197844a68bacdb3d5bf563bd35952176995850933a81
ToppCellLPS_IL1RA_TNF-Mesenchymal_fibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

PTPRD C1S CD302 MMP2 SYNE1 MYOF SYTL4 CD81

3.15e-062001978dc61016c61729f69649cfb21f6264e685ce83dea
ToppCellE18.5-samps-Mesenchymal-Pericyte-pericyte_B|E18.5-samps / Age Group, Lineage, Cell class and subclass

MAP9 BCR GDF9 FAM162B ADAMTSL3 ART3 JRKL

5.02e-0615119778ba15ab24fe2e71df0a2a7511ca451ad2376bd91
Drugmonodansylcadaverine

CLTCL1 CES1 ACO1 AASDHPPT CLTC ARC FGG TGM3 BECN1

6.07e-071112009CID000004247
DrugDasatinib

CES1 MND1 BCR JMY BUB1B KCNK2 C1S CD302 KPNA2 NCAPD3 MMS22L SMC2 EDIL3 AIFM1 PRIM2 EXO1 HAPLN3

1.21e-0647820017ctd:D000069439
DiseaseColorectal Carcinoma

MCF2L2 OBSCN PTPRD PTPRS BUB1B PAN2 MMP2 DMD DNAH8 SYNE1 GPX4 ADAMTSL3 NEURL1 EXO1 PRKCB DSEL EDRF1

5.09e-0670219617C0009402
Diseasehypertrophic cardiomyopathy (is_marker_for)

MMP2 ACE2 BECN1

1.83e-04171963DOID:11984 (is_marker_for)
DiseaseFEV change measurement, response to glucocorticoid

MMS22L DBX1

2.61e-0441962EFO_0005921, GO_0051384
DiseaseMalignant neoplasm of breast

BCORL1 MCF2L2 OBSCN MED14 FABP7 PTPRD MAGED2 MMP2 DMD ALDOA NIPBL PLS3 RAF1 SYNE1 GPX4 CUL5 CSF1 EXO1

3.14e-04107419618C0006142
DiseaseColorectal Neoplasms

PTPRD BUB1B MMP2 SYNE1 GPX4 NEURL1 EXO1 PRKCB

5.58e-042771968C0009404
Diseasebrain ischemia (biomarker_via_orthology)

KCNK2 MMP2 PRKACA BECN1 CTSV

6.08e-041021965DOID:2316 (biomarker_via_orthology)
Diseasecongestive heart failure (biomarker_via_orthology)

KCNK2 MMP2 ALOX12 PRKCB BECN1

7.55e-041071965DOID:6000 (biomarker_via_orthology)
Diseasehypertension (biomarker_via_orthology)

NCF2 HSD3B1 HSD3B2 MMP2 ALOX12 ACE2 BECN1

8.43e-042271967DOID:10763 (biomarker_via_orthology)
DiseaseAbdominal Cryptorchidism

HSD3B2 GPX4

1.20e-0381962C1563730
DiseaseInguinal Cryptorchidism

HSD3B2 GPX4

1.20e-0381962C1563731
DiseaseEmbryonal Rhabdomyosarcoma

BUB1B DMD

1.20e-0381962C0206656
DiseaseBilateral Cryptorchidism

HSD3B2 GPX4

1.20e-0381962C0431663
DiseaseUnilateral Cryptorchidism

HSD3B2 GPX4

1.20e-0381962C0431664
DiseaseLarge cell carcinoma of lung

TRPM6 CASK ROS1

1.24e-03321963C0345958
Diseaseresponse to methylphenidate

SQOR ST6GAL1

1.53e-0391962GO_0036271
Diseasehyperprolactinemia (biomarker_via_orthology)

HSD3B1 HSD3B2

1.53e-0391962DOID:12700 (biomarker_via_orthology)
Diseaseabdominal aortic aneurysm (implicated_via_orthology)

EHF MMP2

1.53e-0391962DOID:7693 (implicated_via_orthology)
DiseaseCryptorchidism

HSD3B2 GPX4

1.91e-03101962C0010417
Diseaseotosclerosis

SEMA4D CRTC1 C11orf16 CSF1

2.11e-03811964EFO_0004213
Diseasepost-traumatic stress disorder symptom measurement

CTTNBP2 PTPRD PIK3CG SYNE1

2.20e-03821964EFO_0008535
Diseasedilated cardiomyopathy (is_marker_for)

OBSCN MMP2 DMD

2.21e-03391963DOID:12930 (is_marker_for)
Diseaseobsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia, anorexia nervosa

TCAIM PLCL1 MYO18A MPHOSPH9 RIMS1 CTNND1

2.26e-032001966EFO_0003756, EFO_0003761, EFO_0003888, EFO_0004242, EFO_0004895, MONDO_0004985, MONDO_0005090, MONDO_0005351
DiseaseParanoia

HSD3B2 DNAH8

2.32e-03111962C1456784
DiseaseX-18913 measurement

ANKRD28 GALNT14

2.32e-03111962EFO_0800795
DiseaseAdenocarcinoma of lung (disorder)

TRPM6 ALDOA KPNA2 RAF1 SCYL2 ROS1

2.62e-032061966C0152013
DiseaseTumoral calcinosis

PTPN6 MMP2 DMD

2.74e-03421963C0263628
DiseaseCalcinosis

PTPN6 MMP2 DMD

2.74e-03421963C0006663
DiseaseMicrocalcification

PTPN6 MMP2 DMD

2.74e-03421963C0521174
Diseasepolycystic ovary syndrome (is_marker_for)

PECAM1 HSD3B2

2.77e-03121962DOID:11612 (is_marker_for)
DiseaseMammary Carcinoma, Human

FABP7 PTPRD MMP2 ALDOA RAF1 SYNE1 GPX4 CUL5 CSF1 EXO1

2.82e-0352519610C4704874
DiseaseMammary Neoplasms, Human

FABP7 PTPRD MMP2 ALDOA RAF1 SYNE1 GPX4 CUL5 CSF1 EXO1

2.82e-0352519610C1257931
DiseaseMammary Neoplasms

FABP7 PTPRD MMP2 ALDOA RAF1 SYNE1 GPX4 CUL5 CSF1 EXO1

2.89e-0352719610C1458155
Diseasehigh grade glioma (implicated_via_orthology)

RAF1 ST6GAL1 CSF1

3.13e-03441963DOID:3070 (implicated_via_orthology)
Diseaseglioblastoma (is_marker_for)

FABP7 MMP2 BECN1

3.13e-03441963DOID:3068 (is_marker_for)
DiseaseAlzheimer disease, cognitive decline measurement, Cognitive impairment

PDS5B ST6GAL1

3.26e-03131962EFO_0007710, HP_0100543, MONDO_0004975
DiseaseBreast Carcinoma

FABP7 PTPRD MMP2 ALDOA RAF1 SYNE1 GPX4 CUL5 CSF1 EXO1

3.35e-0353819610C0678222
Diseasemiddle cerebral artery infarction (biomarker_via_orthology)

ARC CRTC1 ACE2 AIFM1

3.48e-03931964DOID:3525 (biomarker_via_orthology)
Diseasedaytime rest measurement

MYCBP2 SQOR TCAIM NAF1 GMDS SCAF8 PRKCB

3.70e-032951967EFO_0007828
Diseasechromosome 22q11.2 deletion syndrome, distal (implicated_via_orthology)

PI4KA PI4KAP2

3.79e-03141962DOID:0060413 (implicated_via_orthology)
Diseasehippocampal volume

MYCBP2 RABGAP1 SQOR PTPRD PLCL1 BRSK2 ART3

3.84e-032971967EFO_0005035
Diseasecryptococcosis

JMY CSF1

4.35e-03151962EFO_0007229
Diseaseinterferon gamma measurement

ZNF767P PIK3CG ALOX12

4.76e-03511963EFO_0008165
Diseaseresponse to antineoplastic agent, response to antimicrotubule agent

MND1 ARHGAP44

4.95e-03161962EFO_0005260, GO_0097327
DiseaseAbnormal behavior

BCORL1 BRSK2

4.95e-03161962C0233514
DiseaseNecrosis

BCR DMD AIFM1

5.88e-03551963C0027540
Diseaseparental longevity

CTTNBP2 FZR1 PTPRD PRPF40B ANKRD28 GALNT14 PELI2 RUFY3 PRIM2

6.00e-034941969EFO_0007796

Protein segments in the cluster

PeptideGeneStartEntry
FVWARNIGFKVNSKK

ACSBG2

346

Q5FVE4
TFQSHLNKALWKVGK

BUB1B

1026

O60566
GVNAKGQQVFLKDIW

ACO1

576

P21399
DKEVAFWTNLFAKKA

CES1

541

P23141
AEKAVLAANGWNLKN

HSD3B2

161

P26439
QNAKAAFKIWSQKSG

ALDH9A1

56

P49189
NWALKESFIKAIGVG

AASDHPPT

176

Q9NRN7
KLLDSQGKVTKWFNN

BPIFB1

251

Q8TDL5
LLKNKGSLQFEDKWD

CUL5

6

Q93034
TKGQKEAAKGWKEAA

CTCFL

596

Q8NI51
LQGIKTNAKKDGSDW

ACADL

181

P28330
LAEKAVLAANGWNLK

HSD3B1

161

P14060
KKQSGGKTQQYDCKW

BCR

741

P11274
NVTKTLRFKQWNGKE

AIFM1

186

O95831
EWGSNGYVKIAKDKN

CTSV

306

O60911
DKWLNKVTSQNKSFI

AFF2

531

P51816
LQASALKAWGGKKEN

ALDOA

306

P04075
LKAWGGKKENLKAAQ

ALDOA

311

P04075
FKQGSVKNWVEFKKE

ARC

256

Q7LC44
ENAFILDTLKKQWKG

CD302

71

Q8IX05
VKQESVGVFACKNKW

BCORL1

1091

Q5H9F3
INNEWHESKSGKKFA

ALDH1A3

36

P47895
LTKKQFIQCGFAEWK

CEP44

91

Q9C0F1
SLLNKGANVDAKDKW

ANKRD28

671

O15084
SFDIKAQWLKHNKFG

CHIA

341

Q9BZP6
FTKWVNAQFSKFGKQ

DMD

21

P11532
VKGNVANWKISEEFL

SLC7A2

211

P52569
NLEGWKSSKDLKNQL

CENPP

46

Q6IPU0
WGFVNKDQIAKDVKQ

CD81

111

P60033
QAARKKKKLAWGFEA

FAM204A

206

Q9H8W3
FGKLWLSFANDVKQN

AP4E1

1041

Q9UPM8
QRVDAAFNWSKNKKT

MMP2

566

P08253
KGKKARLDWNTDAAS

RAF1

106

P04049
LQSAAGKDAAKQIAW

PDS5B

421

Q9NTI5
SLKEKWNAKSVYVVG

UROS

86

P10746
AQGRQKESGSKWKVF

POGLUT1

21

Q8NBL1
KESGSKWKVFIDQIN

POGLUT1

26

Q8NBL1
GLALNEVQAAKKTWF

RABGAP1

1036

Q9Y3P9
VNGFLADLFTKWKEK

DEPDC5

196

O75140
SKNKEFALADWKELG

PAN2

776

Q504Q3
KQEQQASCTWFGKKK

CASK

691

O14936
KNGVNDIKNHKWFAT

PRKACA

286

P17612
WGQESAQNTKFFKQK

MFAP1

406

P55081
LTKLNNGQKTFDFWK

NT5DC1

146

Q5TFE4
NGQKTFDFWKDIVAA

NT5DC1

151

Q5TFE4
WAKARIQAGAEAKAK

MAGED2

526

Q9UNF1
AARKGEALQAFEKWK

MAP9

506

Q49MG5
ATIAKVGQLFAAWKF

HAPLN3

291

Q96S86
DQKKFGKASWAAAAE

JMY

461

Q8N9B5
IVFVLKKGNDNWATV

NCF2

266

P19878
FAKVKEVDQSGEWFK

MBTD1

371

Q05BQ5
FLQGDCTKAKQKLNW

GMDS

331

O60547
WGSAVAKIIGNNVKK

GPD1L

16

Q8N335
KSVSAAEQQLWKKSF

EDRF1

866

Q3B7T1
KSWAQIFATSKAQKL

MMS22L

951

Q6ZRQ5
GKGIAKVEDTFIKWN

KCNK2

201

O95069
GTLALKQSANWNKFE

LOXHD1

1711

Q8IVV2
LAKKSWFGNFISLEK

BRSK2

516

Q8IWQ3
KTQFNSEEQWTKALK

BECN1

416

Q14457
AINDGNKKSNKIGWE

FSIP2

1606

Q5CZC0
DFINGNKKKWDILGK

MCF2L2

411

Q86YR7
AQKEGWSKAAKLQGR

TSFM

86

P43897
WQKINNFSADIKDSK

PLS3

286

P13797
SKRGFKWKDNILANL

LRRC36

471

Q1X8D7
DNIFAIKSWAKRKFG

MND1

171

Q9BWT6
ISGNKVFSVEKWQAL

MYO18A

521

Q92614
NATQAFWTKQKASKE

PECAM1

551

P16284
NTVKWRKGANTLFKF

CSNKA2IP

716

A0A1B0GTH6
AKLGLKDSQVKIWFQ

DBX1

216

A6NMT0
SGEKIRWTQQSKEFK

DNAH8

3361

Q96JB1
WGQSQEKEKGDKNSA

FYB1

326

O15117
TFSVGNPQEWKKLFK

GXYLT2

176

A0PJZ3
GIKKLVNETFQKLWF

NIPBL

1901

Q6KC79
DEGKIFKNWGTQTEK

MPHOSPH9

751

Q99550
FTSWKEKNQDRSALK

PGM2

356

Q96G03
VNAAGLKNKFDVTWK

HERVK_113

601

P63132
EADGQKISWQAAIFK

PI4KA

1836

P42356
NLEEGNDLKSFWKKL

JRKL

346

Q9Y4A0
LQKASVDGWFKLLSQ

PRKCB

266

P05771
IFWGQKSALAEKVRQ

ALOX12

206

P18054
LEWKNKENQDTGFKF

RALGAPA2

226

Q2PPJ7
VNAAGLKNKFDVTWK

ERVK-7

601

P63135
VNAAGLKNKFDVTWK

ERVK-6

601

Q9BXR3
SQKKGSSWQAKEVKF

KDM5A

1196

P29375
KGKNLLVAVSAEGWF

ITFG2

76

Q969R8
STWQKFAANTGKAKD

NRBF2

241

Q96F24
ALVKWANNAGKVEKC

MED14

101

O60244
WNKKGKKVNSQRFET

PTPRS

66

Q13332
RKQQEILTKSGAWFF

RIMS1

166

Q86UR5
KVKGEDAKSQVWAFT

GALNT14

451

Q96FL9
LSKADFKTQKEAVWA

KPNA2

386

P52292
AQAQTEVTWYKDGKK

OBSCN

1651

Q5VST9
WNRQAAEALGAAKKL

ALPG

31

P10696
EQALQFWKQEFIKGK

PRIM2

321

P49643
VNAAGLKNKFDVTWK

ERVK-18

601

Q9QC07
QKRLDGSVDFKKNWI

FGG

221

P02679
GFVQIWDAAAGKKLS

FZR1

251

Q9UM11
LNKKGLINAWTAAEN

EDIL3

196

O43854
IEWGNFLSRFQKKTK

CD101

601

Q93033
WLKKANEFFNSANKA

CCDC141

351

Q6ZP82
ESKPGKQQWAAFKEQ

CCDC141

676

Q6ZP82
TKNLLDKDWNIFSKN

CSF1

156

P09603
LKVSGKEQAAKNAIW

CPB2

161

Q96IY4
GSYEKSVQLWKKALQ

CPLANE1

841

Q9H799
DKNLSKQAWDTKKTG

CRTC1

196

Q6UUV9
NKKKGESGAWRKVNT

CTTNBP2

1446

Q8WZ74
KSEAVAQLWGKKKNN

EHF

241

Q9NZC4
ADKTNVKAAWGKVGA

HBA1;

6

P69905
IFQTDLTGQKKGWKL

C1S

271

P09871
LFTWLKDQNKNSFVG

ACE2

591

Q9BYF1
EWLKDKGNKLFATEN

DNAAF4

291

Q8WXU2
DSWRNFQANTKGKKE

DNAJC8

221

O75937
SQFEFGKKHKWIQID

GDF9

201

O60383
KLVHIQKWDGKETNF

FABP7

91

O15540
IKWNFTKFLIDKNGC

GPX4

161

P36969
KTAAHVNAWQGKKDQ

CFAP69

641

A5D8W1
IAWALNKGVKTEYKQ

SCAF8

546

Q9UPN6
SKKLWIQFKSNEGNS

SCUBE2

896

Q9NQ36
VDKGSKANIWKQAVV

DSEL

241

Q8IZU8
AEAWLKAKQGKTLDF

CYP4F22

291

Q6NT55
KEGWKKSDFQVNLNN

CTNND1

841

O60716
KAKWREEAALAAQAK

FAM162B

146

Q5T6X4
LLSNSEGGKKAWAKQ

MICAL2

1546

O94851
SKNIFLGEKAAKWKT

PELI1

161

Q96FA3
VWNKKGKKVSNQRFE

PTPRD

56

P23468
WIALVKAAAAAAAKN

PHF20L1

171

A8MW92
ASIKGYQWLKDKVQS

KCNAB3

306

O43448
DDEWTFGSNKNKKKG

RTF1

101

Q92541
LKAKKTFLGQNKSFW

RUFY3

116

Q7L099
WIKEAKNLTAAKAGG

SYTL4

531

Q96C24
FGTNIDLSDNKKWKL

UTY

1031

O14607
EKTWKALQDFKEGNA

SQOR

176

Q9Y6N5
TSWLDNNGKSAVKKL

TCAIM

191

Q8N3R3
QEFQEWFLGAKAAAK

SYNE1

2416

Q8NF91
KAQQLWEGQAASKSF

SYNE1

3236

Q8NF91
DEWTGFNNKVKKATE

SYNE1

5211

Q8NF91
SQDWLAVKEAIKKGN

LRRC56

246

Q8IYG6
ECVFQAQSKWKGAGK

PLCE1

2216

Q9P212
KKDFGNALNWAKQAK

SAMD9

1096

Q5K651
DSSKNIFLGEKAAKW

PELI2

161

Q9HAT8
FKKLSTQGQVDEKWG

SMG1

1466

Q96Q15
GKAVDWAKSGKFTQQ

PITRM1

936

Q5JRX3
RKEFDTNGWQLFSKK

SENP1

576

Q9P0U3
KAKPEASFQVWNKDS

ST6GAL1

86

P15907
AWKIFNGTKKSTKQE

SCYL2

46

Q6P3W7
FKQETGKDRKISNTW

ST6GALNAC5

216

Q9BVH7
WQKKEISLAAASKNS

MYCBP2

161

O75592
QIQDWFSNGIKKAAL

MYCBP2

336

O75592
FWKFQNGVLKAESPK

SEMA4D

586

Q92854
AWVENKTNGKVANLF

SERPINB11

151

Q96P15
QWVDKTKGIFQFVSK

SPIC

131

Q8N5J4
QFVSKNKEKLAELWG

SPIC

141

Q8N5J4
SNNSTEKKFLWKALG

MROH2B

606

Q7Z745
KLADKVNSSWQRKGS

PLPBP

121

O94903
GQKISWQAAIFKLGD

PI4KAP2

306

A4QPH2
KAQQEAWVEKPSFGK

ARHGAP44

241

Q17R89
LNELWKNFGFKKDSE

EXO1

791

Q9UQ84
KFQWIGQAVTLIFKD

SLC25A38

251

Q96DW6
DLQGWLASQKQAAKG

SPTBN5

1741

Q9NRC6
NGSVEILKNWKKSGF

TGM3

251

Q08188
GGKFTEEWKAQFIKT

CMAHP

216

Q9Y471
WKEGQFKDIITKVAN

CLTC

1386

Q00610
WKEGQFKDIITKVAN

CLTCL1

1386

P53675
KVTDAVKCKLNGFQW

NCAPD3

776

P42695
KEITVHFWNGKAAKV

C11orf16

191

Q9NQ32
EVDKFKAKFLTAWNN

ATG4D

61

Q86TL0
GTLEDDFLKAKSWNK

NKAPD1

81

Q6ZUT1
FAKALGDTWLQIKAA

VGLL4

241

Q14135
AAGLKNKFDVTWKLA

ERVK-25

601

P63136
KLFSSVKWGQQEIVA

PIK3CG

591

P48736
KKNGWKTSAGKEVIN

RNASEH1

226

O60930
VKGGVSKAKWLFETQ

XIRP2

626

A4UGR9
KTAVEFGNQLEGKWA

ZNF767P

51

Q75MW2
KGRKLNKATESFAWN

PLCL1

1016

Q15111
SHVESFKVGKNWQKN

USP51

196

Q70EK9
LKHQNSGKWAKSKAI

UTP14C

296

Q5TAP6
QSQKSWIKGVFDKRE

TRPM6

11

Q9BX84
LSKDKKLAQFNNWFT

MIOS

811

Q9NXC5
FANEGNIIAFWVDKK

NEURL1

161

O76050
HVWAQKGAQESKKAD

TNN

776

Q9UQP3
WAQKGNQESKKADTK

TNN

866

Q9UQP3
VHVWAQKGAQESKKA

TNN

951

Q9UQP3
VIWAIKDKAIGNTFF

PYROXD1

171

Q8WU10
WKLLKVGRKNQSFAS

KIF20A

356

O95235
AKVWKIALNVAGKGD

TBC1D23

51

Q9NUY8
VNAAGLKNKFDVTWK

ERVK-10

601

P10266
VNAAGLKNKFDVTWK

ERVK-8

601

P63133
VNAAGLKNKFDVTWK

ERVK-11

601

Q9UQG0
KALFEKWEQETAAGK

SMTNL2

316

Q2TAL5
PGFNSLSFKKKIEWN

TLCD4

36

Q96MV1
LSWSNREKAKQAFKE

PRPF40B

271

Q6NWY9
TWKSKNLKGIFQFRV

ROS1

1816

P08922
AVADAQKRKSKWDSA

SAP30BP

246

Q9UHR5
NIAWQKVNKDFGSIF

SMC2

1031

O95347
NKKQESEDTAKAGFW

PTPN6

231

P29350
KANAESSKTWLKGKF

TRIM14

101

Q14142
WSKLIKNGDIKNAQE

XPOT

306

O43592
GKIQAEFEKKWENGT

SF3A3

211

Q12874
WKGAKNSETAAKVAL

ZFAND1

131

Q8TCF1
VAGLKNKFDVTWKQA

ERVK-19

606

Q9WJR5
KTAVEFGNQLEGKWA

ZNF746

51

Q6NUN9
KDKTVVAYNWKTGNV

WDR31

81

Q8NA23
GFKASEAERQKWKQL

VEZT

591

Q9HBM0
GWLVSIKIAFDKKAQ

POLR1B

391

Q9H9Y6
TFRNLTSIGKKWKDQ

ZNF763

36

Q0D2J5
DVAKNQSFWFINKKS

SMC5

141

Q8IY18
KEFFKISGWEKKLQN

TBC1D19

51

Q8N5T2
FKWGFTGQKTEEVKQ

UGGT1

1236

Q9NYU2
GNSKVNKAQEDDLKW

TMEM87A

506

Q8NBN3
CLAQKTNKAWAKGDI

TMEM91

116

Q6ZNR0
SWFKADLKKAGQESQ

XKR9

61

Q5GH70
ACQGQLKKAASWLFK

VPS13D

2661

Q5THJ4
NSWELKNKQFEAAVK

ADAMTSL3

1071

P82987
GKEWKSALAKLKFAN

DYNLT2

71

Q8IZS6
KWSNVFKVLLEKGFN

L1TD1

806

Q5T7N2
IQTQWKKFGLDSAKL

NAALAD2

86

Q9Y3Q0
ENAKAKWAARKTQIF

ART3

71

Q13508
LKQDKGSDASWKNDQ

NAF1

291

Q96HR8
VNIWLGLSAVEKKFN

MYOF

836

Q9NZM1